| |
Median (IQR) t1a
|
Median (IQR) t1b
|
Median (IQR) t2
|
t1a vs. t1b (ICC)
|
Intragroup comparison t1a vs t2 p (r)
|
Intragroup Δt2-t1a median
|
Intergroup comparison of intragroup Δt2-t1a (p)
|
|---|
|
BPI Intensity
|
|
SMT
|
3.50 (1.75–4.13)
|
3.00 (1.25–5.13)
|
1.13 (0.50–3.44)
|
0.85
|
0.01* (0.63)
|
-1.25
|
0.26
|
|
GE
|
3.00 (2.19–4.19)
|
3.75 (1.50–3.94)
|
2.00 (1.81–3.00)
|
0.07
|
-0.88
|
|
BPI Interference
|
|
SMT
|
1.93 (0.64–3.46)
|
1.57 (0.39–4.11)
|
0.36 (0.11–2.21)
|
0.90
|
≤0.001* (0.83)
|
-0.86
|
0.25
|
|
GE
|
1.50 (0.89–2.82)
|
1.43 (0.64–2.39)
|
0.93 (0.29–2.61)
|
0.17
|
-0.50
|
|
RMDQ
|
|
SMT
|
4.50 (2.00–8.75)
|
6.50 (2.75–10.25)
|
3.50 (1.00–7.00)
|
0.89
|
0.803
|
0.00
|
0.64
|
|
GE
|
5.00 (1.50–6.00)
|
4.00 (2.00–5.00)
|
3.00 (2.00–4.75)
|
0.03* (0.53)
|
-1.00
|
|
ODI
|
|
SMT
|
22.00 (9.50–30.50)
|
22.00 (13.50–32.00)
|
11.00 (6.00–26.50)
|
0.92
|
0.03* (0.51)
|
-3.00
|
0.97
|
|
GE
|
20.00 (12.00–26.67)
|
17.89 (10.50–22.00)
|
16.00 (10.50–21.67)
|
0.03* (0.53)
|
-4.00
|
|
SF-36 PC
|
|
SMT
|
38.62 (32.34–47.65)
|
38.98 (31.56–48.11)
|
46.43 (39.83–52.29)
|
0.91
|
0.01* (−0.67)
|
+6.47
|
0.11
|
|
GE
|
45.47 (37.18–48.20)
|
45.64 (37.40–52.98)
|
47.83 (43.70–52.41)
|
0.15
|
+3.09
|
|
SF-36 MC
|
|
SMT
|
50.51 (45.07–56.34)
|
53.51 (37.39–57.11)
|
55.40 (36.24–59.46)
|
0.94
|
0.94
|
+1.02
|
0.88
|
|
GE
|
54.09 (44.11–58.72)
|
54.20 (47.70–59.23)
|
52.77 (48.62–58.52)
|
0.27
|
+0.66
|
|
2PD [mm]
|
|
SMT
|
64.38 (48.75–76.88)
|
50.63 (46.88–63.75)
|
43.13 (35.00–66.56)
|
0.73
|
0.002* (0.75)
|
-13.13
|
0.09
|
|
GE
|
60.63 (41.88–68.44)
|
58.75 (43.75–68.13)
|
53.13 (39.38–66.56)
|
0.20
|
-3.13
|
|
MCT [number of positive tests]
|
|
SMT
|
4.00 (3.00–4.25)
|
4.00 (3.75–4.00)
|
1.50 (1.00–3.00)
|
0.85
|
≤0.001* (0.86)
|
-2.00
|
0.05*
|
|
GE
|
4.00 (3.00–5.00)
|
4.00 (3.25–5.00)
|
3.50 (2.00–4.75)
|
0.05
|
-1.00
|
|
HADS A
|
|
SMT
|
6.50 (3.00–10.25)
|
6.00 (2.75–11.00)
|
4.50 (2.75–9.25)
|
0.98
|
0.04* (0.50)
|
-1.00
|
0.67
|
|
GE
|
5.50 (2.00–8.75)
|
4.50 (2.00–8.00)
|
4.50 (2.00–8.00)
|
0.10
|
-1.00
|
|
HADS D
|
|
SMT
|
4.00 (1.00–6.00)
|
3.00 (1.00–5.25)
|
2.00 (1.00–5.00)
|
0.97
|
0.04* (0.50)
|
0.00
|
1.00
|
|
GE
|
2.50 (1.00–4.50)
|
2.00 (1.00–4.75)
|
1.00 (0.25–5.75)
|
0.09
|
-1.00
| |
|
FABQ Activity
|
|
SMT
|
12.00 (10.75–15.25)
|
11.50 (8.75–14.50)
|
10.50 (6.75–12.00)
|
0.72
|
0.02* (0.53)
|
-1.50
|
0.44
|
|
GE
|
9.50 (6.25–14.50)
|
10.50 (5.75–16.00)
|
10.00 (5.50–14.75)
|
0.68
|
-1.50
|
|
FABQ Work
|
|
SMT
|
10.50 (2.00–18.00)
|
12.50 (3.75–21.25)
|
9.00 (2.75–19.00)
|
0.87
|
0.50
|
0.00
|
0.07
|
|
GE
|
8.50 (2.00–19.25)
|
10.00 (1.25–15.75)
|
8.50 (1.25–12.00)
|
0.02* (0.57)
|
-2.00
|
- A Anxiety, BPI Brief Pain Inventory, D Depression, FABQ Fear Avoidance and Beliefs Questionnaire, GE General exercise programme, HADS Hospital Anxiety and Depression Scale, ICC Intraclass-correlation coefficient, MC Mental component, MCT Movement control tests, ODI Oswestry Disability Index, PC Physical component, RMDQ Roland Morris Disability Questionnaire, SF-36 Short-Form 36, SMT Specific sensorimotor treatment, t1a first measurement point, t1b second measurement point, t2 follow-up measurement, 2PD two-point discrimination
